Alpa Laboratories Share Price
Alpa Laboratories Share Price Today
As of 5 Jul 2026, Alpa Laboratories share price is ₹69.39. The stock opened at ₹70.00, compared to its previous close of ₹69.09. During today's trading session, Alpa Laboratories share price moved in the range of ₹68.31 to ₹70.00, with an average price of ₹69.16 for the day. Looking at its last 52-week, the stock has touched a low of ₹46.10 and a high of ₹105.90. On the performance front, Alpa Laboratories share price has declined by 11.94% over the last six months and is down 34.25% on a year-on-year basis.
Alpa Laboratories Returns Calculator
Alpa Laboratories Shareholder Returns
Alpa Laboratories Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Alpa Laboratories Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹112.45 | ₹108.74 | ₹92.96 | ₹112.27 |
| Other Income | ₹23.35 | ₹14.89 | ₹9.37 | ₹10.78 |
| Total Revenue | ₹135.80 | ₹123.63 | ₹102.32 | ₹123.04 |
| Total Expenses | ₹110.13 | ₹102.95 | ₹86.43 | ₹103.48 |
| Profit Before Tax | ₹25.67 | ₹20.68 | ₹15.89 | ₹19.56 |
| Tax | ₹6.16 | ₹3.91 | ₹3.31 | ₹5.47 |
| Profit After Tax | ₹19.50 | ₹16.78 | ₹12.58 | ₹14.09 |
| EPS - Basic | ₹9.34 | ₹8.01 | ₹5.88 | ₹6.70 |
| EPS - Diluted | ₹9.34 | ₹8.01 | ₹5.88 | ₹6.70 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹25.82 | ₹20.76 | ₹15.68 | ₹19.56 |
| Income before WC changes | ₹10.10 | ₹11.35 | ₹13.30 | ₹11.60 |
| Change in Assets | -₹11.56 | ₹4.23 | -₹3.82 | ₹8.68 |
| Change in Liabilities | ₹23.85 | -₹8.29 | ₹3.02 | -₹7.23 |
| Change in WC | ₹12.28 | -₹4.06 | -₹0.80 | ₹1.45 |
| Cash flow from Operations | ₹18.32 | ₹3.65 | ₹8.90 | ₹9.94 |
| Cash flow from Investing | -₹12.36 | -₹13.34 | ₹2.13 | -₹15.61 |
| Cash flow from Financing | -₹5.44 | ₹2.58 | -₹3.79 | ₹5.44 |
| Total Cash Flow | ₹0.51 | -₹7.10 | ₹7.24 | -₹0.23 |
| Cash (Start of the year) | ₹3.11 | ₹10.21 | ₹1.58 | ₹1.80 |
| Cash (End of the year) | ₹3.62 | ₹3.11 | ₹8.81 | ₹1.58 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹30.14 | ₹21.39 | ₹18.14 | ₹17.23 |
| Current Assets | ₹192.49 | ₹160.98 | ₹149.13 | ₹138.01 |
| Total Assets | ₹222.63 | ₹182.37 | ₹167.27 | ₹155.24 |
| Current Liabilities | ₹46.70 | ₹28.07 | ₹29.63 | ₹31.38 |
| Net Current Asset | ₹145.79 | ₹132.92 | ₹119.50 | ₹106.63 |
| Non-Current Liabilities | ₹4.49 | ₹2.40 | ₹3.06 | ₹2.12 |
| Equity Capital | ₹171.43 | ₹151.91 | ₹134.58 | ₹121.73 |
| Total Equity & Liabilities | ₹222.63 | ₹182.37 | ₹167.27 | ₹155.24 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹112.45 | ₹108.74 | ₹92.96 | ₹112.27 |
| Other Income | ₹23.31 | ₹14.87 | ₹9.41 | ₹10.79 |
| Total Revenue | ₹135.76 | ₹123.61 | ₹102.36 | ₹123.06 |
| Total Expenses | ₹109.92 | ₹102.94 | ₹86.43 | ₹103.48 |
| Profit Before Tax | ₹25.84 | ₹20.67 | ₹15.93 | ₹19.58 |
| Tax | ₹6.16 | ₹3.90 | ₹3.31 | ₹5.45 |
| Profit After Tax | ₹19.68 | ₹16.78 | ₹12.62 | ₹14.13 |
| EPS - Basic | ₹9.42 | ₹8.01 | ₹5.90 | ₹6.71 |
| EPS - Diluted | ₹9.42 | ₹8.01 | ₹5.90 | ₹6.71 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹25.99 | ₹20.76 | ₹15.72 | ₹19.58 |
| Income before WC changes | ₹10.21 | ₹10.90 | ₹14.25 | ₹11.63 |
| Change in Assets | -₹11.59 | ₹1.72 | -₹3.66 | ₹1.09 |
| Change in Liabilities | ₹23.84 | -₹5.29 | ₹3.20 | -₹6.95 |
| Change in WC | ₹12.25 | -₹3.57 | -₹0.46 | -₹5.85 |
| Cash flow from Operations | ₹18.39 | ₹3.70 | ₹10.20 | ₹2.20 |
| Cash flow from Investing | -₹12.49 | -₹13.45 | ₹1.17 | -₹15.61 |
| Cash flow from Financing | -₹5.48 | ₹2.26 | -₹3.48 | ₹5.41 |
| Total Cash Flow | ₹0.43 | -₹7.49 | ₹7.89 | -₹7.99 |
| Cash (Start of the year) | ₹2.62 | ₹10.14 | ₹2.24 | ₹10.85 |
| Cash (End of the year) | ₹3.05 | ₹2.66 | ₹10.13 | ₹2.85 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹41.53 | ₹32.65 | ₹29.29 | ₹28.33 |
| Current Assets | ₹191.45 | ₹159.77 | ₹148.80 | ₹136.81 |
| Total Assets | ₹232.98 | ₹192.42 | ₹178.09 | ₹165.14 |
| Current Liabilities | ₹46.69 | ₹28.06 | ₹29.92 | ₹28.80 |
| Net Current Asset | ₹144.77 | ₹131.72 | ₹118.88 | ₹108.01 |
| Non-Current Liabilities | ₹4.49 | ₹2.40 | ₹3.06 | ₹4.70 |
| Equity Capital | ₹181.80 | ₹161.97 | ₹145.11 | ₹131.64 |
| Total Equity & Liabilities | ₹232.98 | ₹192.42 | ₹178.09 | ₹165.14 |
About Alpa Laboratories
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Alpa Laboratories Financial Highlights
- Revenue: Alpa Laboratories reported revenue of ₹121.57 crore in FY26 vs ₹135.80 crore in FY25. It showed a decrease of 10.48% on a yearly basis.
- Operating Profit: Alpa Laboratories reported an operating profit of ₹16.70 crore in FY26 vs ₹25.67 crore in FY25. It showed a decrease of 34.94% on a year-on-year basis.
- Net Profit: Alpa Laboratories reported a net profit of ₹15.01 crore in FY26 vs ₹19.50 crore in FY25. It showed a decrease of 23.03% on a yearly basis.
Alpa Laboratories Quarterly Result Highlights
- Alpa Laboratories reported revenue of ₹31.24 crore in Mar 2026, compared with ₹29.96 crore in Dec 2025, representing an increase of 4.27% on a quarter-on-quarter (QoQ) basis.
- Alpa Laboratories reported an operating profit of ₹3.07 crore in Mar 2026, compared with ₹1.75 crore in Dec 2025, representing an increase of 75.43% on a quarter-on-quarter (QoQ) basis.
- Alpa Laboratories reported a profit of ₹1.38 crore in Mar 2026, compared with ₹1.59 crore in Dec 2025, reflecting a decrease of 13.21% on a QoQ basis.
- The earnings per share (EPS) of Alpa Laboratories stood at ₹9.34 during Mar 2026.
Similar Stocks
FAQs on Alpa Laboratories Share Price
What is Alpa Laboratories share price today?
Alpa Laboratories share price is ₹69.39 as on 03 Jul, 2026, 15:29 IST.
How has the Alpa Laboratories share price performed in the past?
In the last 1 year, Alpa Laboratories delivered a return of -34.25%. The Alpa Laboratories share price hit a high of ₹105.90 and low of ₹46.10.
How much is the Mutual Fund shareholding in Alpa Laboratories shares?
The Mutual Fund Shareholding in Alpa Laboratories was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Alpa Laboratories shares ?
The 52-week high and low of Alpa Laboratories share is ₹105.90 and ₹46.10 as of 03 Jul, 2026.
What is the market cap of Alpa Laboratories?
The market capitalisation of Alpa Laboratories is ₹146.74 Crores as on 03 Jul, 2026.
What are the stock symbols of Alpa Laboratories?
The stock symbol of Alpa Laboratories is ALPA on the NSE, 532878 on the BSE, and the ISIN is INE385I01010.
What was yesterday's closing price of Alpa Laboratories shares ?
Alpa Laboratories shares closed yesterday at ₹69.09 on NSE & ₹69.74 on BSE
How to buy Alpa Laboratories shares?
To buy Alpa Laboratories shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Alpa Laboratories shares on Holidays?
No, shares of Alpa Laboratories or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Alpa Laboratories shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Alpa Laboratories?
The PE and PB ratio of Alpa Laboratories is 9.78 and 0.79 respectively, as on 03 Jul, 2026, 15:29 IST.